Invest
Chegg shares tanked 30% in extended trading: here’s why
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Is it time to start buying homebuilder stocks yet?
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Expert: Uber is more protected against inflation than its rivals
Uber Technologies Inc (NYSE: UBER) is a stock that’s more protected against inflation than its rivals, says a senior expert at Morgan Stanley. Shares of
Should I buy Gilead Sciences shares in May 2022?
Gilead Sciences, Inc. (NASDAQ: GILD) shares have weakened from $72.27 to $57.19 since the beginning of January 2022, and the current price stands around $59.39.
Gina Sanchez: ‘Amazon’s going to have the last laugh’
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
A brief recap of Berkshire Hathaway’s 2022 annual meeting
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Activision Blizzard misses first-quarter EPS by 6 cents
Activision Blizzard (NASDAQ: ATVI) recorded a fist-quarter of EPS of about $0.64, 6 cents worse than the $0.7 financial analyst estimates. First-quarter revenue came to
Sell CVS Health for a chance to buy at these potential levels
CVS Health Corporation (NYSE:CVS) stock consolidated at the key level of around $110, signaling that it was time to exit. The healthcare solutions company has
Is it time to buy Alcoa as stock recovers from the post-earnings dip?
When Alcoa Corporation (NYSE:AA) reported its Q1 2022 earnings at least a week ago, investors were less excited. Revenue of $3.29 billion came short of
Should you buy McDonald’s shares after better than expected Q1 results?
McDonald’s Corporation (NYSE: MCD) shares weakened this trading week even though the company reported better than expected first-quarter results. The U.S. stock market remains under